Atlas Trials

Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB

Clinical trial NCT03315182 · TERMINATED

Trial details

NCT number
NCT03315182
Sponsor
Abeona Therapeutics, Inc
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis Type 3 B
Start date
2017-10-16
Primary completion
2022-04-07
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.